To test if these co-stimulatory molecules played a role in local and abscopal tumor control in hRT/lena-treated mice, we blocked CD70, CD83, and CD86 during hRT/lena treatment by co-administration of blocking antibodies. This evidence concerns the gene CD83 and neoplasm.